HDAC7 is a class IIa HDAC that exhibits a lymph-specific expression pattern in the hematopoietic system.[5] DLBCL tumor cells express pan-B cell antigens such as CD19, CD20, CD22, and other B cell transcription factors. This evidence concerns the gene HDAC7 and neoplasm.